Evidence map›Paper›PMID 19168553›Full record

Trial reportClinical chemistry2009

Disposition of MDMA and metabolites in human sweat following controlled MDMA administration.

Allan J Barnes, Bruno S De Martinis, David A Gorelick, Robert S Goodwin, Erin A Kolbrich, Marilyn A Huestis

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Allan J BarnesChemistry and Drug Metabolism and Office of Scientific Director, Intramural Research Program, National Institute on Drug Abuse, NIH, Baltimore MD 21224, USA.
Bruno S De Martinis
David A Gorelick
Robert S Goodwin
Erin A Kolbrich
Marilyn A Huestis
Institute of Forensic Sciences · USNational Institute on Drug Abuse · USUniversidade de São Paulo · BR

Funding

Detection Of Drugs Of Abuse In Alternative Biological Fluids And TissuesZIADA000412 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI SCHEIDWEILER, KARL · 2009 to 2016
$3.9M
Neurobiology and Pharmacokinetics of Acute MDMA AdministrationZIADA000468 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HUESTIS, MARILYN A · 2009 to 2013
$1.9M
Neurobiology /Pharmacokinetics of Acute MDMA AdministratZ01DA000468 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HUESTIS, MARILYN A · 2004 to 2008
$1.2M
Identification Of Factors Associated With Response To Drugs And TreatmentZIADA000241 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI GORELICK, DAVID ALAN · 2009 to 2010
$515k
Intramural NIH HHS Z01 DA000468
6 · The paper itself

Abstract

backgroundUnderstanding the excretion of 3,4-methylenedioxymethamphetamine (MDMA) and metabolites in sweat is vital for interpretation of sweat tests in drug treatment, criminal justice, and workplace programs.

methodsPlacebo, low (1.0 mg/kg), and high (1.6 mg/kg) doses of oral MDMA were given double-blind in random order to healthy volunteers (n = 15) with histories of MDMA use. Participants resided on the closed clinical research unit for up to 7 days after each dose. Volunteers wore PharmChek sweat patches (n = 640) before, during, and after controlled dosing. Patches were analyzed by solid phase extraction and GC-MS for MDMA, methylenedioxyamphetamine (MDA), 4-hydroxy-3-methoxyamphetamine (HMA), and 4-hydroxy-3-methoxymethamphetamine (HMMA). Limits of quantification (LOQ) were 2.5 ng/patch for MDMA and 5 ng/patch for HMA, HMMA, and MDA.

resultsMDMA was the primary analyte detected in 382 patches (59.7%), with concentrations up to 3007 ng/patch. MDA was detected in 188 patches (29.4%) at <172 ng/patch, whereas no HMMA or HMA was detected; 224 patches (35.0%) and 60 patches (9.4%) were positive for MDMA and MDA, respectively, at the 25-ng/patch threshold proposed by the Substance Abuse and Mental Health Services Administration.

conclusionsSweat testing was shown to be an effective and reliable method for monitoring MDMA use in this controlled MDMA administration study. However, variability in sweat excretion suggests that results should be interpreted qualitatively rather than quantitatively. These data provide a scientific database for interpretation of MDMA sweat test results.

Indexed as

AdolescentAdultFemaleHumansMaleN-Methyl-3,4-methylenedioxyamphetamineSweatN-Methyl-3,4-methylenedioxyamphetamine

Identifiers

PMID19168553
PMCPMC2669283
OpenAlexW2160440040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.